AI in Drug Discovery Market to Reach US$ 9,072.2 million by 2030

1
Market Research Report EXCLUSIVE EDITION
Global AI in Drug Discovery Market Report
Opportunities, and Forecast By 2030
Global Industry Analysis, Forecast and Trends,
2030
2
Global AI in Drug Discovery Market 2020
Statsville Consulting Private Limited
Market Statsville Group (MSG) A part of
Statsville Consulting Private Limited American
Office 800 Third Avenue Suite A 1519New York,
NY 10022 EMEA 1165 Budapest 16 Diósy Lajos u.
24., Europe Asia-Pacific Office F-178 Subhash
Marg C Scheme, Ashok Nagar, Jaipur, Rajasthan,
302001 www.marketstatsville.com
Disclaimer Any information and/or material
provided by Statsville Consulting Private
Limited, including any and all the analysis
and/or research from Market Statsville Group
(MSG), is offered to a selected group of
customers in response to orders for such
information, material, analysis, and/or research.
As a customer of Statsville Consulting, you
acknowledge that our information, material,
and/or services are for your internal use only,
and not for any external use and/or
dissemination, or general publication, and/or
disclosure to any third parties. Any and all the
information and/or material provided by
Statsville Consulting are based on primary
interviews and/or secondary research, and are,
therefore, subject to fluctuation and variance.
Statsville Consulting takes no responsibility for
any incorrect information and/or material
supplied to us by sources we rely on, and no part
of our analysis or research may be given, lent,
resold, or disclosed to any third parties,
including non-customers, without explicit or
written permission from Statsville Consulting.
Unauthorized reproduction and/or transmission of
our information, material, analysis, and/or
research in any form and by any means, including
photocopying, mechanical/electronic recording, or
otherwise, without the explicit and written
permission of Statsville Consulting, is expressly
and clearly prohibited. Any use of the
information, material, analysis, and/or research
provided by Statsville Consulting is at your sole
risk you acknowledge that the information,
material, analysis, and/or research is provided
as is and that Statsville Consulting provides
no warranty of any kind, express or implied, with
regard to the information, material, analysis,
and/or research, including but not limited to,
merchantability and fitness for any purpose
and/or use. At the end, Statsville Consulting
will be responsible for the final decision of any
action.
3
ABOUT MARKET STATSVILLE GROUP (MSG)
Market Statsville Group (MSG) partners with
companies and society to confront their essential
risks and challenges to capture the enormous
opportunities for them. MSG was initiated its
working in 2017, and since then, the brand is
moving to become a pioneer in business advisory
and market research services. Market Statsville
is the leading market research and strategy
builder with the depth and breadth of solutions
that perfectly suit your every need. MSG provides
solutions in a wide range of industry verticals
in the form of market sizing, analysis, and
incisive business insights. MSG experienced
research analysts are proficient at digging deep
and providing a variety of customizable data that
help you make decisions with clarity, confidence,
and impact. Market Statsville is your global data
intelligence partner for reliable market research
data, data gathering, and analytical services.
MSG also has an extensive network of top-flight
domestic and global research personals around the
world, enabling us to provide high-quality
worldwide research solutions that cater to a
well-established company, government
organizations, or a startup. MSG's clients have
the authority to work directly with one or more
of our researchers to gather the most useful data
knowledge and analytical plan to formulate it in
the actual practice. Market Statsville Group
believes that to succeed, companies or
individuals must blend digital and human
capabilities most efficiently. MSG diverse and
experienced global team of business consultants
and market researchers will ensure the valuable
reports for our clients through digging in-depth
market information and functional expertise to
continuously spark the changes and real-time
valuation of variation in the market/industry.
MSG works in a uniquely collaborative model
throughout the business process across the globe
to assist the client's company with the most
accurate information that they are aiming for in
the reports.
4
RESEARCH PROCESS
Our research is an optimum culmination of
secondary and primary research, with the latter
playing a major role. We also have an in-house
repository and access to a number of external
regional and global paid databases to help
address specific requirements of our clients. The
research process begins with a holistic secondary
research, followed by expert interviews. The
information gathered is then comprehensively
analyzed by our highly experienced in-house
research panel
5
AI in Drug Discovery Market 2022 Industry Size,
Regions, Emerging Trends, Growth Insights,
Opportunities, and Forecast By 2030
AI in Drug Discovery Market by Offering
(Software, Service), by Technology (Machine
Learning, Others), by Application
(Cardiovascular, Metabolic, Neurodegenerative),
by End User (Pharma, Biotech, and CROs), by
Region Global Share and Forecast to 2030
Description
According to the Market Statsville Group (MSG),
the global AI in drug discovery market size is
expected to grow from USD 910.7 million in
2021 to USD 9,072.2 million by 2030, at a CAGR of
29.1 from 2022 to 2030. A machine that uses
contemporary technology to carry out tasks that
are similar to those carried out by the human
mind is referred to as having artificial
intelligence (AI). Finding drugs that can help
prevent or treat particular diseases is the main
goal of drug discovery research. The need for
artificial intelligence (AI) in the drug
discovery industry was fuelled by the challenges
of assessing, acquiring and using data to tackle
challenging medical problems.
6
The increasing usage of cloud-based apps and
services by pharmaceutical organizations will
help AI flourish in the drug discovery business.
Pharmaceutical vendors are projected to be key
players among the numerous end-users of
cloud-based drug discovery platforms, with a
high-value share of the worldwide cloud-based
drug discovery platform market. According to a
worldwide market potential study, prominent
software suppliers have already embraced
cloud-based drug discovery systems to promote
smooth research and development operations.
Furthermore, the cloud-based drug discovery
platform revolution will increase significantly
in the next years, providing stronger prospects
for software companies to grow and
expand. Request Sample Copy of this
Report https//www.marketstatsville.com/request-s
ample/AI-in-drug-discovery-market COVID-19
Impact on the Global AI in Drug Discovery
Market As many nations fight to manage the
deadly virus, quick medication discovery for
COVID-19 might be a help. Lockdowns and strong
limits on people's movement have had a
detrimental impact, including massive losses for
firms in the AI in the drug development sector.
However, finding a suitable therapy for COVID-19
patients might be beneficial in various ways. A
team of researchers from the University of
Michigan utilized an AI-powered picture to find
over 17 current medications to lower coronavirus
infection in cells. Such tools and techniques aid
in finding current medications' effectiveness
against COVID-19, contributing to AI's expansion
in the drug discovery market.
7
Global AI in Drug Discovery Market
Dynamics Drivers Increasing patent protection
expiration The rising relevance of innovative
drug development due to the increasing patent
expiration of key medications and the increased
outsourcing of formulation development services
by most pharmaceutical and biotechnological
businesses are significant drivers driving market
expansion. Most biopharmaceutical businesses
collaborate with outsourcing services in the
early stages of drug development to mitigate risk
and save time and money as the medicine
progresses through the development
process. Restraints AI workforce shortage AI is
a complicated system requiring a workforce with
certain skill sets to create, manage, and deploy
AI systems. Personnel interacting with AI systems
should be conversant and aware of technologies
such as machine intelligence, deep learning,
cognitive computing, image recognition, and other
AI technologies. Additionally, integrating AI
technology into current systems is a hard
endeavor that demands extensive data processing
to emulate human brain activity. Even little
faults might cause system failure and negatively
affect the desired output. The lack of
professional standards and qualifications in
AI/ML technologies limits AI's growth. Opportuniti
es Mindful AI's Popularity to Provide Huge
Opportunities Mindful AI is quickly becoming an
excellent alternative for creating
pharmaceuticals in a more human-centric and
ethical approach. Mindful AI is an
intention-based technique used for producing
effective AI-based technology. Pharmaceutical
businesses may use conscious AI to learn how
rapidly a medicine can be created and how
inclusive it is in terms of effectiveness. As a
result, the increasing popularity of conscious AI
in the pharmaceutical sector will create
potential development prospects, propelling the
overall AI in the drug discovery market.
8

• Scope of the Global AI in Drug Discovery Market
• The study categorizes AI in the drug discovery
  market based on offering, technology,  end
  user, and application at regional and global
  levels.
• Direct Purchase Report https//www.marketstatsvil
  le.com/buy-now/AI-in-drug-discovery-market?opt295
  0
• By Offering Outlook (Sales, USD Million,
  2017-2030)
• Software
• Services
• By Technology Outlook (Sales, USD Million,
  2017-2030)
• Machine Learning
• Deep Learning
• Supervised Learning
• Reinforcement Learning
• Unsupervised Learning
• Other Machine Learning Technologies
• Other Technologies
• By End User Outlook (Sales, USD Million,
  2017-2030)
• Pharmaceutical Biotechnology Companies
• Contract Research Organizations

9

• By Application Outlook (Sales, USD Million,
  2017-2030)
• Immuno-Oncology
• Neurodegenerative Diseases
• Cardiovascular Diseases
• Metabolic Diseases
• Other Applications
• By Region Outlook (Sales, USD Million, 2017-2030)
• North America
• US
• Canada
• Mexico
• Europe
• Germany
• Italy
• France
• UK
• Spain
• Poland
• Russia

10

• Asia Pacific
• China
• Japan
• India
• South Korea
• Indonesia
• Malaysia
• Thailand
• Singapore
• Australia New Zealand
• Rest of Asia Pacific
• South America
• Brazil
• Argentina
• Colombia
• Rest of South America
• The Middle East Africa
• Saudi Arabia
• UAE

11
Access full Report Description, TOC, Table of
Figure, Chart, etc https//www.marketstatsville.c
om/table-of-content/AI-in-drug-discovery-market D
eep learning accounts for the largest market
share by technology Based on the technology, the
AI in drug discovery market is divided
into machine learning technology and Others. The
machine learning technology segment is further
sub-segmented into deep, supervised,
reinforcement, and unsupervised learning. Deep
learning witnessed the highest market share in
2021 due to the consistent management of data,
saves time, decreases the likelihood of mistakes
in the drug development process, and minimizes
the burden for end users, which are some of the
important aspects driving the market growth of
this segment. North America accounts for the
highest CAGR during the forecast period by
Region Based on the regions, the global AI in
drug discovery market has been segmented across
North America, Asia-Pacific, Europe, South
America, and the Middle East Africa. North
America, being an early adopter of advanced
technologies expected to have the highest CAGR.
North America is home to several important AI
technology suppliers and top startup companies.
Other market drivers include the region's
well-established pharmaceutical sector, a strong
focus on RD with significant RD investments,
and the strong presence of prominent
pharmaceutical firms such as Pfizer (US), Abbott
Laboratories (US), and Johnson Johnson (US). As
a result, such market trends are likely to
assist North America in dominating the overall
market. Request For Report Description https//w
ww.marketstatsville.com/AI-in-drug-discovery-marke
t
12
Thank You
Market Statsville Group (MSG)
F-178 Subhash Marg C Scheme, Ashok Nagar, Jaipur,
Rajasthan, 302001 Phone [phone] Mail
sales_at_marketstatsville.com
800 Third Avenue Suite A 1519 New York, NY
10022 Phone [phone] Mail
sales_at_marketstatsville.com